Oversea Chinese Banking Corp LTD Seagen Inc. Transaction History

Oversea Chinese Banking Corp LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Sep 15, 2023	SELL	$127.59 - $203.08 $73,619 - $117,177	-577 Reduced 16.34%	2,955 $598,000
Q4 2022 Sep 15, 2023	BUY	$117.37 - $139.17 $414,550 - $491,548	3,532 New	3,532 $453,000
Q4 2022 Feb 13, 2023	BUY	$117.37 - $139.17 $414,550 - $491,548	3,532 New	3,532 $0

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Oversea Chinese Banking Corp LTD, based on Form 13F filings with the SEC.

Stay updated on Oversea Chinese Banking Corp LTD with notifications on news.